References
-
Baeuerle, P. A. and D. Baltimore. 1996. NF-
$\kappa$ B: ten years after. Cell 87, 13-20. https://doi.org/10.1016/S0092-8674(00)81318-5 -
Chen, F., V. Castranova, and X. Shi. 2001. New insights into
the role of nuclear factor-
$\kappa$ B in cell growth regulation. Am. J. Pathol. 159, 387-397. https://doi.org/10.1016/S0002-9440(10)61708-7 - Cheung, N. K., U. M. Saarinen, J. E. Neely, B. Landmeier, D. Donovan, and P. F. Coccia. 1985. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 45, 2642-2649.
- Dippold, W. G., K. O. Lloyd, L. T. Li, H. Ikeda, H. F. Oettgen, and L. J. Old. 1980. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 77, 6114-6118. https://doi.org/10.1073/pnas.77.10.6114
- Fields, A. L., D. R. Soprano, and K. J. Soprano. 2007. Retinoids in biological control and cancer. J. Cell Biochem. 102, 886-898. https://doi.org/10.1002/jcb.21530
- Fligiel, S. E., D. R. Inman, H. S. Talwar, G. J. Fisher, J. J. Voorhees, and J. Varani. 1992. Modulation of growth in normal and malignant melanocytic cells by all-trans retinoic acid. J. Cutan Pathol. 19, 27-33. https://doi.org/10.1111/j.1600-0560.1992.tb01555.x
- Fukuda, M., K. Horibe, and K. Furukawa. 1998. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Int. J. Mol. Med. 2, 471-475.
- Hakomori, S. 1996. Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res. 56, 5309-5318.
- Hakomori, S. 1981.lycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50, 733-764. https://doi.org/10.1146/annurev.bi.50.070181.003505
-
Haraguchi, M., S. Yamashiro, A. Yamamoto, K. Furukawa,
K. Takamiya, K. O. Lloyd, H. Shiku, and K. Furukawa. 1994.
Isolation of GD3 synthase gene by expression cloning of
GM3
$\alpha$ -2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc. Natl. Acad. Sci. USA 91, 10455-10459. https://doi.org/10.1073/pnas.91.22.10455 -
Kang, N. Y., C. H. Kim, K. S. Kim, J. H. Ko, J. H. Lee,
Y. K. Jeong, and Y. C. Lee. 2007. Expression of the human
CMP-NeuAc:GM3
$\alpha$ 2,8 sialyltransferase (GD3 synthase) gene through the NF-$\kappa$ B activation in human melanoma SK-MEL-2 cells. Biochim. Biophys. Acta 1769, 622-630. https://doi.org/10.1016/j.bbaexp.2007.08.001 -
Kang, N. Y., S. K Kang, Y. C. Lee, H. J. Choi, Y. S. Lee,
S. Y. Cho, Y. S. Kim, J. H. Ko, and C. H. Kim. 2006.
Transcriptional regulation of the human GD3 synthase gene
expression in Fas-induced Jurkat T cells: a critical role of
transcription factor NF-
$\kappa$ B in regulated expression. Glycobiology 16, 375-389. https://doi.org/10.1093/glycob/cwj087 - Merritt, W. D., J. T. Casper, S. J. Lauer and G. H. Reaman. 1987. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies. Cancer Res. 47, 1724-1730.
- Old, L. J. 1981. Cancer immunology: the search for specificity-G. H. A. Clowes Memorial lecture. Cancer Res. 41, 361-375.
- Pan, M., S. Geng, S. Xiao, J. Ren, Y. Liu, X. Li, Z. Li, and Z. Peng. 2009. Apoptosis induced by synthetic retinoic acid CD437 on human melanoma A375 cells involves RIG-I pathway. Arch. Dermatol. Res. 301, 15-20. https://doi.org/10.1007/s00403-008-0902-x
- Portoukalian, J., G. Zwingelstein, and J. F. Dore. 1979. Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur. J. Biochem. 94, 19-23. https://doi.org/10.1111/j.1432-1033.1979.tb12866.x
- Pukel, C. S., K. O. Lloyd, L. R. Travassos, W. G. Dippold, H. F. Oettgen, and L. J. Old. 1982. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J. Exp. Med. 155, 1133-1147. https://doi.org/10.1084/jem.155.4.1133
- Rusan, S., B. K. Raj, and K. O. Lloyd. 1999. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells. J. Neurochem. 72, 514-521. https://doi.org/10.1046/j.1471-4159.1999.0720514.x
-
Sasaki, K., K. Kurata, N. Kojima, N. Kurosawa, S. Ohta, N.
Hanai, S. Tsuji, and T. Nishi. 1994. Expression cloning of
a GM3-specific
$\alpha$ -2,8-sialyltransferase (GD3 synthase). J. Biol. Chem. 269, 15950-15956. - Sporn, M. B. and A. B. Roberts. 1983. Role of retinoids in differentiation and carcinogenesis, Cancer Res. 43, 3034-3040.
- Svennerholm, L. 1980. Gangliosides and synaptic transmission. Adv. Exp. Med. Biol. 125, 533-544. https://doi.org/10.1007/978-1-4684-7844-0_46
- Thampoe, I. J., K. Furukawa, E. Vellvé, and K. O. Lloyd. 1989. Sialyltransferase levels and ganglioside expression in melanoma and other cultured human cancer cells. Cancer Res. 49, 6258-6264.
- Welte, K., G. Miller, P. B. Chapman, H. Yuasa, E. Natoli, J. E. Kunicka, C. Cordon-Cardo, C. Buhrer, L. J. Old, and A. N. Houghton. 1987. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J. Immunol. 139, 1763-1771.
- Yamaguchi, H., K. Furukawa, S. R. Fortunato, P. O. Livingston, K. O. Lloyd, H. F. Oettgen, and L. J. Old. 1987. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc. Natl. Acad. Sci. USA 84, 2416-2420. https://doi.org/10.1073/pnas.84.8.2416
-
Yamashiro, S., M. Okada, M. Haraguchi, K. Furukawa, K.
O. Lloyd, H. Shiku, and K. Furukawa. 1995. Expression of
$\alpha$ 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconj. J. 12, 894-900. https://doi.org/10.1007/BF00731251 - Zhang, H., S. Zhang, N.-K. V. Cheung, G. Ragupathi, and P. O. Livingston. 1998. Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases. Cancer Res. 58, 2844-2849.